Analysis of complications associated with peripherally inserted central venous catheters. Prospective observational

Marta Ferraz-Torres1, Ana Diez-Revilla2, Ruth Plaza-Unzue3

  • 1PhD, MMCE, RN, University Hospital of Navarra, Navarra, Spain. Associate professor, Department of Health Sciences, Public University of Navarre, E-mail: marta.ferraz@unavarra.esResearcher, IdiSNA, Navarra Institute for Health Research Universidad de Navarra Department of Health Sciences Public University of Navarre Navarra Spain marta.ferraz@unavarra.es.

Revista Cuidarte
|March 21, 2025
PubMed

Insights

Vascular access teams effectively manage peripherally inserted central catheters (PICCs), achieving low complication rates, particularly in onco-hematological patients. Thrombosis and accidental removal were the most frequent complications observed.

Area of Science:

  • Medical Devices
  • Vascular Access
  • Patient Care

Background:

  • Vascular access teams utilize guidelines for device selection.
  • Limited data exists on the performance of these specialized units.
  • Peripherally inserted central catheters (PICCs) are common vascular access devices.

Purpose of the Study:

  • To evaluate the complication rate of PICCs.
  • To analyze the evolution and outcomes of PICCs in patients requiring vascular access.

Main Methods:

  • Prospective observational study over three years.
  • Statistical analysis included Student's t-test, Mann-Whitney U test, chi-square, and Fisher's exact test.
  • Regression analysis was used to determine factors associated with complications.

Main Results:

  • The most frequent complications were accidental removal (3.50%) and thrombosis (3%).
  • Central line-associated bloodstream infection (CLABSI) occurred in 2.10% of cases.
  • PICC dwell time averaged 136 days in oncologic patients and 144 days in hematologic patients.

Conclusions:

  • PICC insertion and management by vascular access teams are associated with a low overall complication rate.
  • Thrombosis and accidental removal are key complications to monitor.
  • Specialized teams contribute to safe and effective PICC utilization in onco-hematological populations.
Abstract